tirzepatide and dopamine on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Tirzepatide attenuates dopamine reward signaling

Audio transcript SPEAKER 1: You're listening to Short Wave from NPR

The effects of neurokinin-1 receptor antagonist in an experimental autoimmune cystitis model resembling bladder pain syndrome/interstitial cystitis

As described previously, SE can induce ROS production through NOX via NMDA receptor activation

This application was not for the President, White House spokesman Kush Desai wrote on X, calling suggestions it was Trump baseless speculation. White House communications director Steven Cheung accused the outlet of peddling falsehoods. (Lizzy Lawrence, the STAT reporter who investigated the alleged retatrutide case, says she reached out multiple times to federal health officials and the White House but did not get direct answers before publication.) A separate White House account accused commentators of spreading bulls*** from the usual suspects by linking Trump to the reported drug request

One issue is that the medication can remain in the body for weeks or even months after treatment stops, depending on the dose and length of the break